| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Viking Therapeutics, Inc. (VKTX) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 19 sells. VKTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.57M | $85.66M | -148,517 | |
| COO | 422.8K | $14.08M | -18,217 | |
| CFO | 212.2K | $7.07M | -21,217 | |
| Dir | 148.0K | $4.93M | - | |
| Dir | 51.1K | $1.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2025 | Rowland Charles A Jr46 | Director | Sale+OE | 60,000 | $35.57 | $2,134,278.00 | -66.7% | -11.7% | - | |
| Jul 3, 2025 | Mancini Marianna53 | Chief Operating Officer | Sell | 4,266 | $27.77 | $118,472.79 | -1.1% | -2.9% | +32.8% | |
| Jul 3, 2025 | Zante Greg53 | Chief Financial Officer | Sell | 4,266 | $27.76 | $118,428.43 | -2.5% | -2.9% | +32.8% | |
| Jul 3, 2025 | Lian Brian52 | President &CEO | Sell | 26,889 | $27.80 | $747,632.51 | -1.1% | -2.9% | +32.8% | |
| Mar 31, 2025 | Rouan Sarah Kathryn49 | Director | Buy | 1,240 | $24.15 | $29,942.78 | New | +9.7% | +34.7% | |
| Jan 6, 2025 | Lian Brian52 | President &CEO | Sell | 194,490 | $42.75 | $8,313,601.16 | -3.9% | -50.0% | -24.1% | |
| Jan 6, 2025 | Mancini Marianna53 | Chief Operating Officer | Sell | 54,215 | $42.75 | $2,317,599.12 | -6.7% | -50.0% | -24.1% | |
| Jan 6, 2025 | Zante Greg53 | Chief Financial Officer | Sell | 50,309 | $42.75 | $2,150,594.66 | -13.0% | -50.0% | -24.1% | |
| Nov 8, 2024 | MacArtney Lawson | Director | Sale+OE | 2,000 | $68.67 | $137,333.40 | -4.0% | -54.1% | -46.3% | |
| Oct 28, 2024 | Zante Greg53 | Chief Financial Officer | Sale+OE | 131,687 | $76.61 | $10,089,164.06 | -8.3% | -55.1% | -53.1% |